相关实验视频
Updated: Jun 10, 2025
05:46
Establishing a Diaphyseal Femur Fracture Model in Mice
Published on: December 9, 2022
1.9K
骨质疏松骨中骨折非结合:当前的做法和未来的方向
Chijioke Orji1, Charles Ojo2, Daniel E Onobun3
1Department of Trauma and Orthopedics, Liverpool University Hospitals NHS Foundation Trust, Liverpool, GBR.
Cureus
|October 21, 2024
概括
骨质疏松性骨中骨折非结合是日益增长的骨科挑战. 像干细胞和3D打印这样的新型疗法提供了超越传统治疗方法的有希望的个性化解决方案.
科学领域:
- 整形外科 整形外科 整形外科
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
背景情况:
- 骨质疏松性骨折由于骨质不佳和愈合受损而构成重大挑战.
- 全球人口老龄化增加了骨质疏松性骨折的发生率,导致延迟愈合和非结合率更高.
- 病理生理学涉及到骨再生受损,骨质母细胞活性降低和骨质疏松患者的血管性差.
研究的目的:
- 审查骨质疏松骨中骨折非结合管理方面的挑战和进展.
- 探索新的治疗策略和新兴技术来治疗骨质疏松性非结合症.
- 讨论不断发展的诊断方法和这些复杂骨折的个性化医学的未来方向.
主要方法:
- 审查包括药理和手术干预在内的传统管理策略.
- 对再生医学,生长因子,干细胞,基因疗法和生物活性支架的最新进展进行分析.
- 检查新兴技术,如3D打印和纳米技术在骨科应用.
- 评估最新的诊断方法,包括放射性评估和生物标志物.
主要成果:
- 由于骨质疏松性骨的性质受到损害,传统治疗往往表现出有限的成功.
- 新型疗法提供有针对性的,生物驱动的解决方案,有可能改善结果.
- 先进的诊断技术有助于更好地识别非工会风险.
- 新兴技术使定制治疗策略成为可能.
结论:
- 骨质疏松性骨中骨折非结合性骨折需要综合方法,将传统和创新疗法结合起来.
- 个性化医疗和进一步的临床验证对于优化结果至关重要.
- 新兴的策略代表了朝着更有效地管理这些复杂的骨科病例的重大转变.
相关概念视频
01:27Fractures: Bone Repair
3.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.0K
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K